204 related articles for article (PubMed ID: 36232463)
1. Formulation, Characterisation and Evaluation of the Antihypertensive Peptides, Isoleucine-Proline-Proline and Leucine-Lysine-Proline in Chitosan Nanoparticles Coated with Zein for Oral Drug Delivery.
Khalid Danish M; Gleeson JP; Brayden DJ; Byrne HJ; Frías JM; Ryan SM
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232463
[TBL] [Abstract][Full Text] [Related]
2. Formulation, Characterization and Stability Assessment of a Food-Derived Tripeptide, Leucine-Lysine-Proline Loaded Chitosan Nanoparticles.
Danish MK; Vozza G; Byrne HJ; Frias JM; Ryan SM
J Food Sci; 2017 Sep; 82(9):2094-2104. PubMed ID: 28796309
[TBL] [Abstract][Full Text] [Related]
3. Application of Box-Behnken experimental design for the formulation and optimisation of selenomethionine-loaded chitosan nanoparticles coated with zein for oral delivery.
Vozza G; Danish M; Byrne HJ; Frías JM; Ryan SM
Int J Pharm; 2018 Nov; 551(1-2):257-269. PubMed ID: 30153488
[TBL] [Abstract][Full Text] [Related]
4. Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition.
Gleeson JP; Frías JM; Ryan SM; Brayden DJ
Eur J Pharm Biopharm; 2018 Jul; 128():179-187. PubMed ID: 29684535
[TBL] [Abstract][Full Text] [Related]
5. Nutraceutical formulation, characterisation, and in-vitro evaluation of methylselenocysteine and selenocystine using food derived chitosan:zein nanoparticles.
Vozza G; Khalid M; Byrne HJ; Ryan SM; Frias JM
Food Res Int; 2019 Jun; 120():295-304. PubMed ID: 31000242
[TBL] [Abstract][Full Text] [Related]
6. Zein-derived peptides as nanocarriers to increase the water solubility and stability of lutein.
Jiao Y; Zheng X; Chang Y; Li D; Sun X; Liu X
Food Funct; 2018 Jan; 9(1):117-123. PubMed ID: 29336438
[TBL] [Abstract][Full Text] [Related]
7. Effects of bioactive peptides isoleucine-proline-proline (IPP), valine-proline-proline (VPP) and leucine-lysine-proline (LKP) on gene expression of osteoblasts differentiated from human mesenchymal stem cells.
Huttunen MM; Pekkinen M; Ahlström ME; Lamberg-Allardt CJ
Br J Nutr; 2007 Oct; 98(4):780-8. PubMed ID: 17466096
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-zein nano-in-microparticles capable of mediating in vivo transgene expression following oral delivery.
Farris E; Brown DM; Ramer-Tait AE; Pannier AK
J Control Release; 2017 Mar; 249():150-161. PubMed ID: 28153762
[TBL] [Abstract][Full Text] [Related]
9. Layer-by-layer assembly of quercetin-loaded zein/γPGA/low-molecular-weight chitosan/fucoidan nanosystem for targeting inflamed blood vessels.
Lu HY; Mi FL; Chou CM; Lin C; Chen YY; Chu CY; Liu CY; Lee YA; Shih CC; Cheng CH
Int J Biol Macromol; 2024 May; 267(Pt 1):131369. PubMed ID: 38580026
[TBL] [Abstract][Full Text] [Related]
10. Stability, toxicity and intestinal permeation enhancement of two food-derived antihypertensive tripeptides, Ile-Pro-Pro and Leu-Lys-Pro.
Gleeson JP; Heade J; Ryan SM; Brayden DJ
Peptides; 2015 Sep; 71():1-7. PubMed ID: 26048090
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of PEG-coated zein nanoparticles for oral drug delivery purposes.
Reboredo C; González-Navarro CJ; Martínez-Oharriz C; Martínez-López AL; Irache JM
Int J Pharm; 2021 Mar; 597():120287. PubMed ID: 33524523
[TBL] [Abstract][Full Text] [Related]
12. Chitosan coating of zein-carboxymethylated short-chain amylose nanocomposites improves oral bioavailability of insulin in vitro and in vivo.
Ji N; Hong Y; Gu Z; Cheng L; Li Z; Li C
J Control Release; 2019 Nov; 313():1-13. PubMed ID: 31622690
[TBL] [Abstract][Full Text] [Related]
13. Coated chitosan nanoparticles encapsulating caspase 3 activator for effective treatment of colorectral cancer.
Jain A; Jain S; Jain R; Kohli DV
Drug Deliv Transl Res; 2015 Dec; 5(6):596-610. PubMed ID: 26334865
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of PepT1 transport of food-derived antihypertensive peptides, Ile-Pro-Pro and Leu-Lys-Pro using in vitro, ex vivo and in vivo transport models.
Gleeson JP; Brayden DJ; Ryan SM
Eur J Pharm Biopharm; 2017 Jun; 115():276-284. PubMed ID: 28315445
[TBL] [Abstract][Full Text] [Related]
15. Zein-casein-lysine multicomposite nanoparticles are effective in modulate the intestinal permeability of ferulic acid.
Heep G; Almeida A; Marcano R; Vieira D; Mainardes RM; Khalil NM; Sarmento B
Int J Biol Macromol; 2019 Oct; 138():244-251. PubMed ID: 31279877
[TBL] [Abstract][Full Text] [Related]
16. Food Protein Based Core-Shell Nanocarriers for Oral Drug Delivery: Effect of Shell Composition on in Vitro and in Vivo Functional Performance of Zein Nanocarriers.
Alqahtani MS; Islam MS; Podaralla S; Kaushik RS; Reineke J; Woyengo T; Perumal O
Mol Pharm; 2017 Mar; 14(3):757-769. PubMed ID: 28103046
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
18. Formulation of Chitosan-Zein Nano-in-Microparticles for Oral DNA Delivery.
Heck K; Farris E; Pannier AK
Methods Mol Biol; 2024; 2720():165-176. PubMed ID: 37775665
[TBL] [Abstract][Full Text] [Related]
19. Fabrication, characterization and functional attributes of zein-egg white derived peptides (EWDP)-chitosan ternary nanoparticles for encapsulation of curcumin: Role of EWDP.
Liu J; Li Y; Zhang H; Liu S; Yang M; Cui M; Zhang T; Yu Y; Xiao H; Du Z
Food Chem; 2022 Mar; 372():131266. PubMed ID: 34628117
[TBL] [Abstract][Full Text] [Related]
20. Zein-based nanoparticles for the oral delivery of insulin.
Inchaurraga L; Martínez-López AL; Martin-Arbella N; Irache JM
Drug Deliv Transl Res; 2020 Dec; 10(6):1601-1611. PubMed ID: 32514704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
